ArticleJournal of neuroinflammation2016

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.

Catalina Abad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.